Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -28.63% is 269% below its 2-year average of -7.76%, near the low end of its 2-year range (-44.37%–35.80%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.78% above its 12-month average of -35.69%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -28.63%.
RETURN ON INVESTED CAPITAL (ROIC)
-28.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-35.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.78%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
+16.87%
vs the sector median at left
Maze Therapeutics, Inc.
Market Cap
$1.44B
Return on Invested Capital (ROIC)
-28.63%
TTM Avg
-35.69%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.45B
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.44B
Return on Invested Capital (ROIC)
-53.48%
TTM Avg
-44.88%
3Y Avg
-46.83%
5Y Avg
-39.47%
Market Cap
$1.42B
Return on Invested Capital (ROIC)
47.55%
TTM Avg
-5.71%
3Y Avg
-17.68%
5Y Avg
-14.30%
Market Cap
$1.46B
Return on Invested Capital (ROIC)
16.83%
TTM Avg
6.43%
3Y Avg
6.32%
5Y Avg
5.53%
Market Cap
$1.42B
Return on Invested Capital (ROIC)
5.22%
TTM Avg
4.86%
3Y Avg
3.97%
5Y Avg
3.44%
Market Cap
$1.45B
Return on Invested Capital (ROIC)
0.59%
TTM Avg
0.35%
3Y Avg
-0.10%
5Y Avg
-0.25%
Market Cap
$1.47B
Return on Invested Capital (ROIC)
-35.66%
TTM Avg
-26.24%
3Y Avg
-27.95%
5Y Avg
-27.95%
Market Cap
$1.48B
Return on Invested Capital (ROIC)
-19.87%
TTM Avg
-24.87%
3Y Avg
-20.19%
5Y Avg
-15.68%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Maze Therapeutics, Inc. (MAZE) | $1.44B | -28.63% | -35.69% | N/A | N/A |
| Braveheart Bio, Inc. (BRVE)vs › | $1.45B | N/A | N/A | N/A | N/A |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.44B | -53.48% | -44.88% | -46.83% | -39.47% |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 47.55% | -5.71% | -17.68% | -14.30% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.46B | 16.83% | 6.43% | 6.32% | 5.53% |
| The Pennant Group, Inc. (PNTG)vs › | $1.42B | 5.22% | 4.86% | 3.97% | 3.44% |
| Certara, Inc. (CERT)vs › | $1.45B | 0.59% | 0.35% | -0.10% | -0.25% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | -35.66% | -26.24% | -27.95% | -27.95% |
| GH Research PLC (GHRS)vs › | $1.48B | -19.87% | -24.87% | -20.19% | -15.68% |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.41B | -24.52% | -24.52% | -24.52% | -24.52% |
ROIC
-28.6%
ROE
-29.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -28.63% |
| 2026-03-31 | -33.64% |
| 2025-12-31 | -38.15% |
| 2025-09-30 | -33.65% |
| 2025-06-30 | -44.37% |
| 2025-03-31 | 15.62% |
| 2024-12-31 | 25.62% |
| 2024-09-30 | 35.80% |
| 2024-06-30 | 31.59% |
